NCT04246021 2022-01-04
Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy
King Hussein Cancer Center
Phase NA Completed
Clinical Trials
6 trialsNCT02469480 2020-10-19
Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT03625661 2018-08-10
CAMARA
Institut Cancerologie de l'Ouest
Phase NA Completed
NCT02125344 2017-07-13
A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
GBG Forschungs GmbH
Phase 3 Completed
NCT01701310 2016-10-28
IVICA
Nottingham University Hospitals NHS Trust
Phase 4 Completed
NCT02057471 2014-02-07
Intravenous Iron: Measuring Response in Anemic Surgical Patients
Nottingham University Hospitals NHS Trust
Phase 4 Completed